RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.190
+0.080 (7.21%)
At close: Nov 20, 2024, 4:00 PM
1.290
+0.100 (8.40%)
Pre-market: Nov 21, 2024, 7:00 AM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $28.54 million as of November 21, 2024. Its market cap has increased by 130.12% in one year.
Market Cap
28.54M
Enterprise Value
18.98M
1-Year Change
130.12%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $28.54M, a decrease of -58.42%. That is a compound annual growth rate of -23.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 28.54M | 16.56% |
Dec 29, 2023 | 24.49M | 14.54% |
Dec 30, 2022 | 21.38M | -50.41% |
Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GeoVax Labs | 27.46M |
Daré Bioscience | 27.18M |
MiNK Therapeutics | 27.16M |
Acurx Pharmaceuticals | 27.13M |
IGC Pharma | 26.57M |
Longeveron | 26.57M |
Allurion Technologies | 26.41M |
Lipocine | 25.46M |